Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Preservia Holding PREF | PHOLPREF | Apr 30, 2024 | 11.40 | 0.00 |
Preservia Hyresfastigheter B | PHYRB | Apr 30, 2024 | 0.12 | 0.00 |
Preservia Hyresfastigheter PREF | PHYRPREF | Apr 30, 2024 | 43.00 | 0.00 |
Preservium Property | PRESRV | Apr 30, 2024 | 25.60 | 0.00 |
Prevas B | PREVB | Apr 30, 2024 | 119.40 | -1.16 |
Pricer B | PRICB | Apr 30, 2024 | 11.46 | -2.55 |
Proact IT Group | PACT | Apr 30, 2024 | 104.60 | +0.19 |
Probi | PROB | Apr 30, 2024 | 203.00 | 0.00 |
ProfilGruppen B | PROFB | Apr 30, 2024 | 123.50 | +2.07 |
Profoto Holding | PRFO | Apr 30, 2024 | 73.80 | +3.07 |
Projektengagemang Sweden B | PENGB | Apr 30, 2024 | 11.55 | +0.43 |
Prolight Diagnostics | PRLD | Apr 30, 2024 | 0.16 | -4.91 |
Promimic AB | PRO | Apr 30, 2024 | 27.20 | -0.37 |
ProstaLund | PLUN | Apr 30, 2024 | 0.98 | +0.20 |
Prostatype Genomics | PROGEN | Apr 30, 2024 | 0.04 | +7.22 |
Provide IT | PROVIT | Apr 30, 2024 | 1.79 | -4.79 |
Purefun | PURE | Apr 30, 2024 | 11.30 | -1.31 |
Q-Linea | QLINEA | Apr 30, 2024 | 2.60 | -10.82 |
QBank | QBNK | Apr 30, 2024 | 7.10 | +20.34 |
Qbrick | QBRICK | Apr 30, 2024 | 0.23 | 0.00 |
Qiiwi Games | QIIWI | Apr 30, 2024 | 2.50 | +6.38 |
QleanAir | QAIR | Apr 30, 2024 | 31.40 | -1.88 |
Qlife Holding | QLIFE | Apr 30, 2024 | 0.00 | -6.67 |
Qliro | QLIRO | Apr 30, 2024 | 23.45 | +0.43 |
Qlosr Group B | QLOSRB | Apr 30, 2024 | 1.25 | +0.81 |
Qlucore | QCORE | Apr 30, 2024 | 7.85 | +1.95 |
Quartiers Properties | QUART | Apr 30, 2024 | 12.30 | -3.53 |
Quartiers Properties Pref | QUARTPREF | Apr 30, 2024 | 10.30 | 0.00 |
Quartiers Properties PREF | QARTMTFPREF | Apr 30, 2024 | 10.30 | 0.00 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | Apr 30, 2024 | 0.10 | +17.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.